TNL Mediagene (TNMG)
NASDAQ:TNMG
Top Page
TNL Mediagene
(NASDAQ:TNMG)
Select Model
Select Model
Rating:41Neutral
Price Target:
$3.00
▲(62.16% Upside)
Action:UpgradedDate:01/17/26
The score is primarily held down by very weak financial performance—severe losses, negative cash flow, and elevated leverage despite strong revenue growth. Technicals add downside risk given the broader downtrend (below key longer-term moving averages and negative MACD). Valuation is also constrained by ongoing losses (negative P/E) and no dividend support.
Positive Factors
Revenue Growth
A 35.3% year-over-year revenue increase in 2024 shows durable demand for TNL’s digital content and advertising services. Strong top-line momentum supports scale effects, audience monetization, and provides a base to invest in product, content, or sales capabilities that can improve long-term profitability if cost structure is addressed.
Negative Factors
Severe Profitability Shortfall
Extremely negative EBIT and net margins indicate core operations destroy value relative to revenue. Such deep losses erode equity, limit reinvestment capacity, force recurring external financing, and raise execution risk for any growth strategy until meaningful margin improvement is achieved.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
A 35.3% year-over-year revenue increase in 2024 shows durable demand for TNL’s digital content and advertising services. Strong top-line momentum supports scale effects, audience monetization, and provides a base to invest in product, content, or sales capabilities that can improve long-term profitability if cost structure is addressed.
Read all positive factors
TNL Mediagene (TNMG) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$4.73M
Dividend YieldN/A
Average Volume (3M)11.02M
Price to Earnings (P/E)―
Beta (1Y)3.24
Revenue Growth4.59%
EPS Growth-920.22%
CountryUS
Employees500
SectorHealthcare
Sector Strength45
IndustryPublishing
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,556,405
10 Day Avg. Volume12,249,583
30 Day Avg. Volume11,015,397
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)5.35
Price to Sales (P/S)4.01
P/FCF Ratio-18.89
Enterprise Value/Market Cap4.45
Enterprise Value/Revenue0.35
Enterprise Value/Gross Profit1.27
Enterprise Value/Ebitda-0.29
Forecast
1Y Price Target
$14.00Price Target Upside656.76% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
TNL Mediagene Business Overview & Revenue Model
Company Description
TNL Mediagene operates as a media company in Taiwan and Japan. The company operates The News Lens, a news site; Business Insider Japan, a news site focused on developments inside and outside Japan in business, finance, politics, and technology; Bu...
How the Company Makes Money
TNMG generates revenue through multiple streams, primarily by offering subscription-based services, licensing agreements for its proprietary content, and advertising partnerships. The company has established significant collaborations with healthc...
TNL Mediagene Financial Statement Overview
Summary
Income Statement
20
Very Negative
Balance Sheet
30
Negative
Cash Flow
15
Very Negative
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
Income Statement | ||||
| Total Revenue | 60.57M | 48.49M | 35.84M | 20.01M |
| Gross Profit | 16.54M | 17.74M | 12.65M | 7.74M |
| EBITDA | -73.81M | -73.92M | 1.33M | -10.01M |
| Net Income | -83.41M | -85.00M | -804.98K | -11.01M |
Balance Sheet | ||||
| Total Assets | 86.05M | 92.92M | 119.62M | 26.53M |
| Cash, Cash Equivalents and Short-Term Investments | 1.90M | 3.65M | 3.03M | 3.91M |
| Total Debt | 20.24M | 23.14M | 17.59M | 6.71M |
| Total Liabilities | 51.19M | 56.51M | 47.25M | 50.67M |
| Stockholders Equity | 34.86M | 36.40M | 72.62M | -25.30M |
Cash Flow | ||||
| Free Cash Flow | -11.21M | -10.30M | -1.68M | -1.04M |
| Operating Cash Flow | -11.13M | -10.21M | -1.42M | -760.11K |
| Investing Cash Flow | 475.34K | 947.95K | 252.74K | -2.36M |
| Financing Cash Flow | 9.21M | 10.00M | 530.97K | 4.99M |
TNL Mediagene Technical Analysis
Negative
1.85
Price Trends
2.87
Negative
3.78
Negative
6.10
Negative
Market Momentum
-0.29
Positive
28.38
Positive
9.62
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TNMG, the sentiment is Negative. The current price of 1.85 is below the 20-day moving average (MA) of 2.38, below the 50-day MA of 2.87, and below the 200-day MA of 6.10, indicating a bearish trend. The MACD of -0.29 indicates Positive momentum. The RSI at 28.38 is Positive, neither overbought nor oversold. The STOCH value of 9.62 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TNMG.
TNL Mediagene Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
44 Neutral | $2.22M | -12.91 | -50.26% | ― | -66.59% | 67.63% | |
44 Neutral | $8.36M | -1.88 | ― | ― | ― | ― | |
43 Neutral | $1.70M | -6.52 | ― | ― | -62.46% | -12.90% | |
41 Neutral | $4.73M | -1.60 | -164.27% | ― | 4.59% | -920.22% | |
| ― | $2.81M | -22.59 | -194.72% | ― | -11.51% | 74.52% |
* Healthcare Sector Average
TNMG
TNL Mediagene
1.85
-13.35
-87.83%
CNET
ZW Data Action Technologies
0.68
-0.80
-54.05%
BAOS
Baosheng Media Group Holdings
2.52
0.41
19.43%
DRCT
Direct Digital Holdings
0.77
-34.43
-97.82%
VSME
VS Media Holdings Limited Class A
1.02
-18.00
-94.64%
FTRK
Fast Track Group
0.38
-2.90
-88.32%
TNL Mediagene Corporate Events
TNL Mediagene Regains Nasdaq Bid-Price Compliance but Faces One-Year Listing Monitor
Jan 22, 2026
On January 20, 2026, TNL Mediagene received confirmation from Nasdaq that it had regained compliance with the exchange’s minimum bid price requirement, after the company’s ordinary shares closed at or above $1.00 for 15 consecutive tra...
TNL Mediagene Wins Conditional Nasdaq Listing Extension Pending $1 Bid Price Compliance
Dec 29, 2025
On December 23, 2025, TNL Mediagene was informed by a Nasdaq Hearings Panel that its request for continued listing on the Nasdaq Capital Market had been granted, provided it regains compliance with Nasdaq’s $1 bid price requirement (Listing ...
TNL Mediagene Announces 1-for-20 Reverse Split to Restore Nasdaq Compliance
Dec 19, 2025
On December 19, 2025, TNL Mediagene announced it will implement a 1-for-20 share consolidation of its ordinary shares, following shareholder approval on December 2, 2025 and board approval of the final ratio on December 9, 2025. The reverse split,...
TNL Mediagene Amends Note Agreement and Issues Second Tranche
Dec 12, 2025
On December 8, 2025, TNL Mediagene amended its securities purchase agreement with 3i, LP, issuing a second tranche convertible note valued at $1,666,667. This amendment introduces revised terms for future note issuances, including an 18-month matu...
TNL Mediagene Announces Shareholder Meeting Results and Strategic Changes
Dec 5, 2025
On December 5, 2025, TNL Mediagene announced the results of its Annual General Meeting of Shareholders held on December 2, 2025. The meeting, initially convened on November 25, 2025, saw all proposals approved, including an increase in authorized ...
TNL Mediagene Appoints New Auditor Amid Internal Control Concerns
Dec 1, 2025
TNL Mediagene, a company operating in the media industry, announced a change in its certifying accountant. On October 9, 2025, PricewaterhouseCoopers, Taiwan, declined to stand for re-election as the independent registered public accounting firm f...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.